Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 796 Records) |
| Query Trace: Lung Neoplasms and IMPACT[original query] |
|---|
| Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01. Targeted oncology 2024 9 . Makoto Hibino, Yoshinori Imamura, Rai Shimoyama, Tomoya Fukui, Ryuta Fukai, Akihiko Iwase, Yukihiro Tamura, Yusuke Chihara, Takafumi Okabe, Kiyoaki Uryu, Tadahisa Okuda, Masataka Taguri, Hironobu Mina |
| Immunohistochemistry of p53 surrogates TP53 mutation as an accurate predictor for early-relapse of surgically resected stage I-III lung adenocarcinoma. JTCVS open 2024 9 20 183-193. Yasuyuki Kurihara, Takayuki Honda, Akira Takemoto, Katsutoshi Seto, Satoshi Endo, Kousuke Tanimoto, Susumu Kirimura, Masashi Kobayashi, Shunichi Baba, Yasuhiro Nakashima, Ryo Wakejima, Rie Sakakibara, Hironori Ishibashi, Johji Inazawa, Toshihiro Tanaka, Yasunari Miyazaki, Kenichi Oku |
| Assessing the Sensitivity of Nested PCR Followed by Direct Sequencing on Exosomal DNA for EGFR Mutation Detection in NSCL. Iranian biomedical journal 2024 9 28 (4): 208-15. Mohammad Mehdi Jahani, Parisa Mashayekhi, Mir Davood Omrani, Adnan Khosravi, Dehghanifard Ali, Sanam Azad Manjiri, Mahyar Zahraei, Maryam Mabani, Sharareh Seifi, Babak Salimi, Parsa Rosta |
| Causal Relationships Between Emotional Instability and Respiratory Diseases: A Mendelian Randomization Analysis. Psychology research and behavior management 2024 9 17 3159-3167. Xinlai Ma, Yang Zhang, Yuxiao Sun, Hongyu Mou, Wei Zha |
| The causal and mediation effect of chronic obstructive pulmonary disease on lung cancer subtypes: a two-sample mendelian randomization study. Cancer causes & control : CCC 2024 9 . Xue Zhang, Jinze Zhang, Zhe Wa |
| Increased inflammatory signature in myeloid cells of non-small cell lung cancer patients with high clonal hematopoiesis burden. eLife 2024 12 13 . Hyungtai Sim, Hyun Jung Park, Geun-Ho Park, Yeon Jeong Kim, Woong-Yang Park, Se-Hoon Lee, Murim Ch |
| Impact of ABCG2 rs2231142(421C>A) Variant on the Clinical Outcomes of Patients With EGFR-mutated Non-small Cell Lung Cancer Treated With Gefitinib: A Comprehensive Meta-analysis. Anticancer research 2024 12 44 (12): 5361-5370. Francisco Cezar Aquino DE Moraes, Maria Eduarda Cavalcanti Souza, Emanuele Rocha DA Silva, Michele Kreuz, Rommel Mario Rodriguez Burba |
| Cathepsin L in Lung Adenocarcinoma: Prognostic Significance and Immunotherapy Response Through a Multi Omics Perspective. Cancer informatics 2024 12 23 11769351241307492. Jianming Lu, Jiaqi Liang, Gang Xiao, Zitao He, Guifang Yu, Le Zhang, Chao Cai, Gao Yi, Jianjiang X |
| Prognostic impact of EGFR mutations in T1-4N0M0 lung adenocarcinoma: analyses focus on imaging and pathological features. Journal of thoracic disease 2024 12 16 (11): 7244-7256. Jing-Yu Chen, Ying Zhu, Bao-Cong Liu, Hui-Yun Ma, Lu-Jie Li, Mei-Cheng Chen, Shu-Chang Zhou, Xiang-Min Li, Jian-Ting Long, Qiong |
| Prognostic impact of targetable driver alterations in resected early-stage lung cancer. Translational lung cancer research 2024 12 13 (11): 3096-3105. Angelika Terbuch, Selma Konjic, Verena Schlintl, Gudrun Absenger, Philipp J Jost, Jörg Lindenmann, Paul Swatek, Nikolaus John, Teresa John, Robert Wurm, Martin Zacharias, Florian Posch, Maximilian J Hochmair, Hannah Fabikan, Christoph Weinlinger, Oliver Illini, Lena Horvath, Gabriele Gamerith, Dominik Wolf, Florian Augustin, Luka Brc |
| EGFR exon 20 insertion mutation and MET exon 14 skipping mutation in non-small cell lung cancer: a scoping review in the Chinese population. Translational lung cancer research 2024 12 13 (11): 3224-3240. Xiao-Rong Yang, Si-Min Zhong, Zhen-Yi Jin, X?n Gào, Ying Wu, Qing Zhou, Yang-Qiu Li, Si-Yang Maggie Liu, Yi-Long |
| Sex and common germline variants impact the toxicity profile and pharmacokinetics of alectinib: a nation-wide cohort study in patients with ALK-positive non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 12 . Niels Heersche, Daan A C Lanser, M Benthe Muntinghe-Wagenaar, Ma Ida Mohmaed Ali, Ezgi B Ulas, Tessa M A Trooster, Evert de Jonge, Esther Oomen-de Hoop, Marthe S Paats, Idris Bahce, Sander Croes, Lizza E L Hendriks, Anthonie J van der Wekken, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H N van Schaik, Ron H J Mathijssen, G D Marijn Veerm |
| LncRNA RNF144A-AS1 gene polymorphisms and their influence on lung cancer patients in the Chinese Han population. Non-coding RNA research 2024 11 10 252-260. Hongjiao Wu, Yuning Xie, Ang Li, Xiyao Liu, Liwen Guo, Fengjun Wu, Zhenbang Yang, Zhi Zhang, Xuemei Zha |
| Association of hTERT MNS16A polymorphism with clinical outcomes of North Indian lung cancer patients undergoing platinum-based doublet chemotherapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 11 . Ishmeet Kaur, Heena Kansal, Sidhartha Singh, Navneet Singh, Siddharth Shar |
| Pooled Analysis of the Prognostic Significance of Epidermal Growth Factor Receptor (EGFR) Mutational Status in Combination with Other Driver Genomic Alterations in Stage I Resected Invasive Lung Adenocarcinoma for Recurrence-Free Survival: A Population-Based Study. Annals of surgical oncology 2024 11 . Yufei Huang, Hui Zeng, Guochao Zhang, Fangzhou Ren, Zhenlong Yuan, Jingyu Ren, Jiaxi Xu, Zehao Song, Wenbin Li, Jianming Ying, Feiyue Feng, Fengwei T |
| MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study. BMC cancer 2024 11 24 (1): 1384. Xiaojun Cai, Jing Lin, Caili Li, Ting Xu, Chuanben Chen, Bin Lan, Xuefeng Wang, Shengjie Bai, Yufang Huang, Huishan Zhang, Lu Si, Yu Ch |
| Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer. Clinical lung cancer 2024 10 . Alexander S Watson, Harris B Krause, Andrew Elliott, Alex Farrell, Stephen V Liu, Patrick C Ma, Ari VanderWalde, George W Sledge, David Spetzler, Erin L Schenk, D Ross Camid |
| Association between smoking status and the prognosis of brain metastasis in patients with non-small cell lung cancer. Frontiers in oncology 2024 10 14 1403344. Xiaofang Zhang, Weilin Zeng, Xingyu Yan, Zheng Wang, Ke Xu, Mo Li, Tianlu Wang, Yingqiu So |
| Efficacy and Tolerance of First-Line Afatinib in Elderly NSCLC Patients with EGFR Mutations in Vietnam: A Multicenter Real-World Study. Asian Pacific journal of cancer prevention : APJCP 2024 10 25 (10): 3567-3576. Tu Anh Do, Hoa Thi Thai Nguyen, Phuong Cam Pham, Khoi Tuan Nguyen, Thu Thi Anh Hoang, Anh Tuan Le, Hao Dinh Thy Vuong, Tam Dac Nhan Nguyen, Khiem Van Dang, Oanh Thi Nguyen, Luan Van Pham, Hai Minh Nguyen, Trang Thi Huyen Vo, Do Hung Kien, Thanh Ha Vu, Hang Thi Thuy Nguyen, Thai Van Pham, Huy Le Trinh, Gia Hoang Nguyen, Minh Cong Truong, Chau Tran Minh Pham, Phuong Thi Bich Nguy |
| Impact of select actionable genomic alterations on efficacy of neoadjuvant immunotherapy in resectable non-small cell lung cancer. Journal for immunotherapy of cancer 2024 10 12 (10): . Nicolas Zhou, Cheuk H Leung, William N William, Annikka Weissferdt, Apar Pataer, Myrna C B Godoy, Brett W Carter, Frank V Fossella, Anne S Tsao, George R Blumenschein, Xiuning Le, Jianjun Zhang, Ferdinandos Skoulidis, Jonathan M Kurie, Mehmet Altan, Charles Lu, Bonnie S Glisson, Lauren A Byers, Yasir Y Elamin, Reza J Mehran, David C Rice, Garrett L Walsh, Wayne L Hofstetter, Jack A Roth, Hai T Tran, Jia Wu, Luisa M Solis Soto, Humam Kadara, Stephen G Swisher, Ara A Vaporciyan, Don L Gibbons, Heather Y Lin, J Jack Lee, John V Heymach, Marcelo V Negrao, Boris Sepesi, Tina Casco |
| Association between fruit intake and non-small cell lung cancer: a Mendelian randomization study. Translational lung cancer research 2024 10 13 (9): 2388-2394. Chongde Pan, Ying Du, Yu Jiang, Yuechun Lin, Yulin Zhao, Huiwen Yu, Hengrui Liang, Wanzhe Liao, Xin Xu, Ying Hua |
| CYP3A4 gene expression discloses individual differences in postoperative pain susceptibility and drug treatment response in patients with lung cancer. International journal of clinical and experimental pathology 2024 10 17 (9): 287-297. Xiunan Jia, Xi Nan, Shiqi Diao, Dongxin Wang, Tongrao Wang, Dongmei Fu, Chunyan Ni, Ying Chang, Jixin Liu, Xitong Zhang, Hongling Cao, Xiaoyu Zhang, Dongxue Li, Qing Zu, Gang Liu, Zongming L |
| Obesity and survival in advanced non-small cell lung cancer patients treated with chemotherapy, immunotherapy, or chemoimmunotherapy: a multicenter cohort study. BMC medicine 2024 10 22 (1): 463. Wei Nie, Jun Lu, Jie Qian, Shu-Yuan Wang, Lei Cheng, Liang Zheng, Guang-Yu Tao, Xue-Yan Zhang, Tian-Qing Chu, Bao-Hui Han, Hua Zho |
| The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer affect tumor stem-like property by Wnt/?-catenin pathway. Cell death & disease 2024 10 15 (10): 738. Yu Liu, Lingling Fang, Yalong Wang, Tao Fan, Liyu Wang, Chu Xiao, Ziqin Deng, Wenpeng Cai, Bo Zheng, Junfeng Qiu, Chunxiang Li, Jie |
| Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA. Investigational new drugs 2025 1 . Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, Shun-Ichi Isa, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Masahiro Shimada, Masahiko Ando, Yasuhiro K |
| Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 2025 1 10 (24): e40703. Liqun Li, Zhe Huang, Yangqian Chen, Hongzhi Ma, Xiaoquan Chen, Huan Yan, Haoyue Qin, Yuda Zhang, Xing Zhang, Wenjuan Jiang, Zhan Wang, Lin Zhang, Fanxu Zeng, Zhiguo Zhou, Xingxiang Pu, Nong Yang, Liang Zeng, Yongchang Zha |
| Real-World Incidence of Anaplastic Lymphoma Kinase alterations in Hispanics with Non-Small Cell Lung Cancer at a Large Academic Institution in Los Angeles. Cancer research communications 2025 1 . Darin Poei, Sana Ali, Jacob S Thomas, Jorge J Nieva, Robert C H |
| TP53 germline testing and hereditary cancer: how somatic events and clinical criteria affect variant detection rate. Genome medicine 2025 1 17 (1): 3. Paula Rofes, Carmen Castillo-Manzano, Mireia Menéndez, Álex Teulé, Sílvia Iglesias, Elisabet Munté, Mireia Ramos-Muntada, Carolina Gómez, Eva Tornero, Esther Darder, Eva Montes, Laura Valle, Gabriel Capellá, Marta Pineda, Joan Brunet, Lidia Feliubadaló, Jesús Del Valle, Conxi Láza |
| Brief report: Impact of consolidation durvalumab on unresectable non-small lung cancer with driver mutations. Cancer treatment and research communications 2025 1 42 100863. Jason C S Ho, K M Cheu |
| Impact of co-mutations and transcriptional signatures in non-small cell lung cancer patients treated with adagrasib in the KRYSTAL-1 trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2025 1 . Marcelo V Negrao, Alvaro G Paula, David Molkentine, Laura Hover, Monique Nilsson, Natalie Vokes, Lars Engstrom, Andrew Calinisan, David M Briere, Laura Waters, Jill Hallin, Lixia Diao, Mehmet Altan, George R Blumenschein, Ferdinandos Skoulidis, Jing Wang, Scott E Kopetz, David S Hong, Don L Gibbons, Peter Olson, James G Christensen, John V Heyma |
- Page last reviewed:Feb 1, 2024
- Content source: